U.S. House · 119th Congress · H.R. 9418
Access to Innovative Treatments Act of 2026
To amend title XVIII of the Social Security Act to provide a review process for adverse national coverage determinations with respect to drug coverage under the Medicare program.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Nanette Diaz BarragánD-CA-44
- Introduced
- June 24, 2026, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- John JoyceR-PA-13